Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 11:46 am Purchase | 2025-09-30 | 13G | DOUYU INTL HLDGS LTD SPONSORED DOYU | Morgan Stanley MS | 2,175,260 7.200% | 2,175,260 (New Position) | Filing History |
| 2025-11-07 11:45 am Purchase | 2025-09-30 | 13G | CLEARBRIDGE ENERGY MIDSTREAM O EMO | Morgan Stanley MS | 1,535,805 8.300% | 360,720 (+30.70%) | Filing History |
| 2025-11-07 11:43 am Purchase | 2025-09-30 | 13G | INSIGHT ENTERPRISES INC NSIT | Morgan Stanley MS | 2,015,926 6.400% | 383,678 (+23.51%) | Filing History |
| 2025-11-07 11:43 am Sale | 2025-09-30 | 13G | ENVISTA HLDGS CORP COM NVST | Morgan Stanley MS | 10,129,212 6.100% | -4,011,858 (-28.37%) | Filing History |
| 2025-11-07 11:42 am Purchase | 2025-09-30 | 13G | ABRDN INCOME CREDIT STRATEGIES ACP | Morgan Stanley MS | 6,588,286 5.300% | 721,071 (+12.29%) | Filing History |
| 2025-11-07 11:39 am Sale | 2025-09-30 | 13G | VIRTUS CONVERTIBLE & INCOME FU NCZ | Morgan Stanley MS | 1,949,265 10.200% | -206,979 (-9.60%) | Filing History |
| 2025-11-07 11:11 am Sale | 2025-09-30 | 13G | ABRDN INCOME CREDIT STRATEGIES ACP | Morgan Stanley MS | 5,867,215 4.700% | -1,448,640 (-19.80%) | Filing History |
| 2025-11-04 09:51 am Purchase | 2025-11-03 | 13D | MORGAN STANLEY MS | MITSUBISHI UFJ FINANCIAL GROUP INC MUFG | 380,010,887 23.910% | 1,048,077 (+0.28%) | Filing History |
| 2025-10-07 4:15 pm Sale | 2025-09-30 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Morgan Stanley MS | 116,406 0.700% | -1,332,654 (-91.97%) | Filing History |
| 2025-10-07 4:12 pm Sale | 2025-09-30 | 13G | ESSA PHARMA INC EPIX | Morgan Stanley MS | 1,904,062 4.000% | -2,282,516 (-54.52%) | Filing History |
| 2025-09-08 4:33 pm Purchase | 2025-08-31 | 13G | EVOKE PHARMA INC PAR $0.00 EVOK | Morgan Stanley MS | 163,718 10.500% | 163,718 (New Position) | Filing History |
| 2025-08-07 4:21 pm Sale | 2025-07-31 | 13G | CHEMOMAB THERAPEUTICS LTD CMMB | Morgan Stanley MS | 3,303,315 3.200% | -4,767,355 (-59.07%) | Filing History |
| 2025-08-07 4:16 pm Purchase | 2025-07-31 | 13G | GUGGENHEIM TAXABLE MUNI BOND & GBAB | Morgan Stanley MS | 2,799,316 10.400% | 415,605 (+17.44%) | Filing History |
| 2025-08-07 4:15 pm Sale | 2025-07-31 | 13G | BIOMX INC PHGE | Morgan Stanley MS | 0 0.000% | -97,581 (Position Closed) | Filing History |
| 2025-08-07 3:20 pm Purchase | 2025-06-30 | 13G | BETA BIONICS INC BBNX | Morgan Stanley MS | 2,928,838 6.800% | 2,928,838 (New Position) | Filing History |
| 2025-08-07 3:18 pm Purchase | 2025-06-30 | 13G | BLOOM ENERGY CORP BE | Morgan Stanley MS | 11,939,835 5.100% | 9,730,811 (+440.50%) | Filing History |
| 2025-08-07 3:04 pm Purchase | 2025-06-30 | 13G | ROIVANT SCIENCES LTD SHS ROIV | Morgan Stanley MS | 37,646,676 5.500% | 37,646,676 (New Position) | Filing History |
| 2025-08-07 2:59 pm Sale | 2025-06-30 | 13G | WHITE MOUNTAINS INSRN GRP,LTD WTM | Morgan Stanley MS | 159,020 6.200% | -26,591 (-14.33%) | Filing History |
| 2025-08-07 12:55 pm Purchase | 2025-06-30 | 13G | FACTSET RESEARCH SYSTEMS INC FDS | Morgan Stanley MS | 2,167,472 5.700% | 2,167,472 (New Position) | Filing History |
| 2025-08-07 12:50 pm Purchase | 2025-06-30 | 13G | C4 THERAPEUTICS INC CCCC | Morgan Stanley MS | 4,750,383 6.700% | 921,573 (+24.07%) | Filing History |